Laurence-Moon-Bardet-Biedl syndrome
Also known as: Bardet Biedl Syndrome (BBS) / Bardet-Biedl Syndrome / Bardet Biedl Syndrome / Bardet-Biedl Syndrome (BBS) / Bardet-Biedl syndrome (disorder) / Laurence-Moon syndrome / Laurence-Moon syndrome (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11700 | Setmelanotide | Setmelanotide is indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB11700 | Setmelanotide | Melanocortin receptor 4 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00331 | Metformin | 2 | Withdrawn | 1 |
| DB11700 | Setmelanotide | 3 | Completed | 3 |
| DB11700 | Setmelanotide | Not Available | Approved for Marketing | 1 |